Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
Crizotinib (PF-02341066)
Cat No.
CEI-0046
Description
Crizotinib (PF-02341066) can inhibit c-Met and ALK with IC50 of 11 nM and 24 nM.
CAS No.
877399-52-5
Molecular Weight
450.34
Purity
>99%
Storage
2 years at -20centigrade Powder
Targets
ALK, c-Met
Molecular Formula
C21H22CL2FN5O
Chemical Name
3-((R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine
Solubility
DMSO 20 mg/mL Water
In vitro
As an ATP-competitive, small-molecule inhibitor, crizotinib (PF-02341066), c-Met (also known as hepatocyte growth factor receptor) and anaplastic lymphoma kinase (ALK).Crizotinib inhibited the growth and survival of cell lines dependent upon c-Met or ALK enzymatic activity.Crizotinib has been particularly effective against anaplastic large cell lymphoma and non-small cell lung cancer (NSCLC) cell lines, and that NSCLC cell lines harbors ALK translocations which would lead to expression of oncogenic ALK fusion proteins.
Download
Download Datasheet